References
Original article
Curtis, J. R. et al. Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2022-222543 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McHugh, J. Cancer and cardiovascular risk with JAK inhibition. Nat Rev Rheumatol 19, 64 (2023). https://doi.org/10.1038/s41584-022-00901-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-022-00901-5
- Springer Nature Limited